Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67151 - 67175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	MOGAT3	346606	downregulated	rosiglitazone results in decreased expression of MOGAT3 mRNA	7q22.1	A22609
Rosiglitazone	Approved Investigational	MS4A10	341116	downregulated	rosiglitazone results in decreased expression of MS4A10 mRNA	11q12.2	A22609
Rosiglitazone	Approved Investigational	MTMR11	10903	downregulated	rosiglitazone results in decreased expression of MTMR11 mRNA	1q21.2	A22609
Rosiglitazone	Approved Investigational	MTSS1	9788	downregulated	rosiglitazone results in decreased expression of MTSS1 mRNA	8q24.13	A22609
Rosiglitazone	Approved Investigational	MYC	4609	downregulated	rosiglitazone results in decreased expression of MYC mRNA	8q24.21	A24127
Rosiglitazone	Approved Investigational	NBL1	4681	upregulated	rosiglitazone results in increased expression of NBL1 mRNA	1p36.13	A24100
Rosiglitazone	Approved Investigational	NCF2	4688	downregulated	rosiglitazone results in decreased expression of NCF2 mRNA	1q25.3	A24128
Rosiglitazone	Approved Investigational	NDN	4692	upregulated	rosiglitazone results in increased expression of NDN mRNA	15q11.2	A24114
Rosiglitazone	Approved Investigational	NDRG2	57447	downregulated	rosiglitazone results in decreased expression of NDRG2 mRNA	14q11.2	A10216
Rosiglitazone	Approved Investigational	NDUFAF2	91942	upregulated	rosiglitazone results in increased expression of NDUFAF2 mRNA	5q12.1	A22609
Rosiglitazone	Approved Investigational	NEDD9	4739	downregulated	rosiglitazone results in decreased expression of NEDD9 mRNA	6p24.2	A20427
Rosiglitazone	Approved Investigational	NOX4	50507	downregulated	rosiglitazone results in decreased expression of NOX4 mRNA	11q14.3	A22609
Rosiglitazone	Approved Investigational	NR1H3	10062	upregulated	rosiglitazone results in increased expression of NR1H3 mRNA	11p11.2	A22612 A23649
Rosiglitazone	Approved Investigational	NREP	9315	downregulated	rosiglitazone results in decreased expression of NREP mRNA	5q22.1	A20427
Rosiglitazone	Approved Investigational	NRIP1	8204	upregulated	rosiglitazone results in increased expression of NRIP1 mRNA	21q11.2-q21.1	A10216
Rosiglitazone	Approved Investigational	NRP1	8829	downregulated	rosiglitazone results in decreased expression of NRP1 mRNA	10p11.22	A24100
Rosiglitazone	Approved Investigational	NT5E	4907	downregulated	rosiglitazone results in decreased expression of NT5E mRNA	6q14.3	A22609
Rosiglitazone	Approved Investigational	NUAK1	9891	downregulated	rosiglitazone results in decreased expression of NUAK1 mRNA	12q23.3	A20427
Rosiglitazone	Approved Investigational	NUDT7	283927	downregulated	rosiglitazone results in decreased expression of NUDT7 mRNA	16q23.1	A10216
Rosiglitazone	Approved Investigational	OLR1	4973	upregulated	rosiglitazone results in increased expression of OLR1 mRNA	12p13.2	A10216
Rosiglitazone	Approved Investigational	OMA1	115209	upregulated	rosiglitazone results in increased expression of OMA1 mRNA	1p32.2-p32.1	A10216
Rosiglitazone	Approved Investigational	ORAI3	93129	downregulated	rosiglitazone results in decreased expression of ORAI3 mRNA	16p11.2	A20427
Rosiglitazone	Approved Investigational	OSGIN1	29948	upregulated	rosiglitazone results in increased expression of OSGIN1 mRNA	16q23.3	A20427
Rosiglitazone	Approved Investigational	OTC	5009	downregulated	rosiglitazone results in decreased expression of OTC mRNA	Xp11.4	A22609
Rosiglitazone	Approved Investigational	PALD1	27143	downregulated	rosiglitazone results in decreased expression of PALD1 mRNA	10q22.1	A10216

Displaying entries 67151 - 67175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability